169 related articles for article (PubMed ID: 1360276)
1. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
Chaudhary PM; Roninson IB
Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
[TBL] [Abstract][Full Text] [Related]
2. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine.
Komarov PG; Shtil AA; Holian O; Tee L; Buckingham L; Mechetner EB; Roninson IB; Coon JS
Oncol Res; 1998; 10(4):185-92. PubMed ID: 9778689
[TBL] [Abstract][Full Text] [Related]
3. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
[TBL] [Abstract][Full Text] [Related]
4. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI
Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242
[TBL] [Abstract][Full Text] [Related]
5. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
[TBL] [Abstract][Full Text] [Related]
7. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
9. Effect of protein kinase C on multidrug resistance of multidrug-resistant colorectal cancer LoVo/Adr cells.
Ma Q; Zhang ZS; Zhang YL; Wang QY; Lai ZS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):626-8. PubMed ID: 12376294
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
Nieuwint AW; Baas F; Wiegant J; Joenje H
Cancer Res; 1992 Aug; 52(16):4361-71. PubMed ID: 1353703
[TBL] [Abstract][Full Text] [Related]
11. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
12. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro.
Dlugosz AA; Yuspa SH
Cancer Res; 1991 Sep; 51(17):4677-84. PubMed ID: 1678684
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.
Rao VV; Chiu ML; Kronauge JF; Piwnica-Worms D
J Nucl Med; 1994 Mar; 35(3):510-5. PubMed ID: 7906729
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
15. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
Drew L; Groome N; Warr JR; Rumsby MG
Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C activation and protooncogene expression in differentiation/retrodifferentiation of human U-937 leukemia cells.
Hass R; Pfannkuche HJ; Kharbanda S; Gunji H; Meyer G; Hartmann A; Hidaka H; Resch K; Kufe D; Goppelt-Strübe M
Cell Growth Differ; 1991 Nov; 2(11):541-8. PubMed ID: 1814434
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
Schwartz GK; Arkin H; Holland JF; Ohnuma T
Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824
[TBL] [Abstract][Full Text] [Related]
18. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
Bhat UG; Winter MA; Pearce HL; Beck WT
Mol Pharmacol; 1995 Oct; 48(4):682-9. PubMed ID: 7476894
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.
Comerford KM; Wallace TJ; Karhausen J; Louis NA; Montalto MC; Colgan SP
Cancer Res; 2002 Jun; 62(12):3387-94. PubMed ID: 12067980
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]